Arecor Therapeutics plc (AIM:AREC)

Market Cap	24.92M +55.3%
Revenue (ttm)	1.71M -66.1%
Net Income	664.00K
EPS	0.02
Shares Out	37.76M
PE Ratio	23.51
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,896
Average Volume	13,720
Open	70.00
Previous Close	66.00
Day's Range	62.00 - 70.00
52-Week Range	35.40 - 100.00
Beta	-0.20
RSI	38.98
Earnings Date	Apr 13, 2026

About Arecor Therapeutics

Arecor Therapeutics plc, a clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom. The company through its proprietary reformulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo which is used to treat severe hypoglycaemia events in patients with diabetes;...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 44
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AREC